(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.
Mediwound's earnings in 2025 is -$30,224,000.On average, 5 Wall Street analysts forecast MDWD's earnings for 2025 to be -$30,652,282, with the lowest MDWD earnings forecast at -$31,947,449, and the highest MDWD earnings forecast at -$28,601,601. On average, 4 Wall Street analysts forecast MDWD's earnings for 2026 to be -$25,012,910, with the lowest MDWD earnings forecast at -$30,112,629, and the highest MDWD earnings forecast at -$21,370,253.
In 2027, MDWD is forecast to generate -$17,304,508 in earnings, with the lowest earnings forecast at -$22,125,767 and the highest earnings forecast at -$12,519,946.